Evolutionary ecology meets the antibiotic crisis-Reference-Cited by-同舟云学术

Evolutionary ecology meets the antibiotic crisis

Published:2019-01-01 Issue:1 Volume:2019 Page:37-45
ISSN:2050-6201
Container-title:Evolution, Medicine, and Public Health
language:en
Short-container-title:

Author:

Roemhild Roderich¹²^ORCID,Schulenburg Hinrich¹²^ORCID

Affiliation:

1. Department of Evolutionary Ecology and Genetics, Zoological Institute, Christian-Albrechts-Universität zu Kiel, Am Botanischen Garten 1-9, Kiel, Germany

2. Antibiotic Resistance Evolution Group, Max-Planck-Institute for Evolutionary Biology, August-Thienemann-Str. 2, Plön, Germany

Funder

German Science Foundation

Leibniz Science Campus Evolutionary Medicine of the Lung

Max-Planck Society

Publisher

Oxford University Press (OUP)

Subject

Health, Toxicology and Mutagenesis,Ecology, Evolution, Behavior and Systematics,Medicine (miscellaneous)

Link

http://academic.oup.com/emph/article-pdf/2019/1/37/28096006/eoz008.pdf

Reference55 articles.

1. Clinical management of resistance evolution in a bacterial infection: a case study;Woods;Evol Med Public Health,2015

2. Multidrug evolutionary strategies to reverse antibiotic resistance;Baym;Science,2016

3. Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa;Vestergaard;Int J Antimicrob Agents,2016

4. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals;Bergstrom;Proc Natl Acad Sci USA,2004

5. Executive summary: official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis;Nahid;Clin Infect Dis,2016

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The many dimensions of combination therapy: How to combine antibiotics to limit resistance evolution;Evolutionary Applications;2024-08

2. β-lactamase expression induces collateral sensitivity in Escherichia coli;Nature Communications;2024-06-03

3. The mechanisms and clinical potential of collateral sensitivity in Mycobacterium tuberculosis: A literature review;The Microbe;2024-06

4. Evolution of E. coli in a mouse model of inflammatory bowel disease leads to a disease-specific bacterial genotype and trade-offs with clinical relevance;Gut Microbes;2023-12-07

5. The many dimensions of combination therapy: How to combine antibiotics to limit resistance evolution;2023-11-29